Treatments - Health Technology Insights

New CHD Book Total Load Theory Tackling Toxic Overload

November 25, 2025

Moonlight Therapeutics Gets FDA Clearance for MOON101 Trial

October 17, 2025

CVS Health Helps Improve Access to More Affordable Fertility Treatments

October 17, 2025

Next Health Forms Scientific Advisory Council for Longevity

October 15, 2025

Micro Interventional Devices Gets FDA Nod for STTAR-US Trial

October 15, 2025

Pelage Pharmaceuticals Raises $120 Million Series B to Boost Hair Loss Treatments

October 15, 2025

Mission Therapeutics Raises $13.3 Million for Parkinson’s Drug Trials

October 15, 2025

Clinical Data Backs Rapid SUBLOCADE Induction for Opioid Use Disorder

October 15, 2025

FDA Approves Tecentriq with Lurbinectedin for Lung Cancer

FDA Approves Tecentriq with Lurbinectedin for Lung Cancer

October 3, 2025

HUA TUO Acupuncture Needles Launch in U.S. via TCMzone Arizona

October 3, 2025

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

October 2, 2025

AAVantgarde Gains FDA Orphan Status for Stargardt Drug

October 2, 2025

Recent Posts

Health Technology Insights: Latest News And Innovations – Roundup 26 November 2025

FluidAI Medical Announces an Acquisition Deal With Emmetros Limited

Healgen Highlights Rapid Check Test for COVID-19 and Flu Season

Alleva Earns ONC Certification, SOC 2, and HIPAA Compliance

Tangram Therapeutics Files CTA for TGM-312 Phase 1/2 Study

Tangram Therapeutics Files CTA for TGM-312 Phase 1/2 Study

Herantis Pharma Announces Successful Completion of Six-Month Glp Toxicology Study of Her-096

Herantis Pharma Announces Successful Completion of Six-Month Glp Toxicology Study of Her-096